Eris Lifesciences Limited — Call Transcript 2024

Oct 23, 2024

==> picture [594 x 125] intentionally omitted <==

Date: 23 October 2024

To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai- 400001 Bandra (E) Mumbai-400051 Security Code: 540596 Symbol: ERIS

SUBJECT: INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL PURSUANT TO REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (“SEBI (LODR) Regulations, 2015”)

Dear Sir/Madam,

This is further to our letter dated October 22, 2024, intimating about the date of the Board of Directors Meeting to, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended September 30, 2024.

We wish to inform that pursuant to regulation 30 and other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, the Company will hold a conference call for analysts and investors on Friday, October 25, 2024, at 04:30 p.m. IST. The details of the said call are attached herewith and is also available on Company’s website.

Thanking you.

For Eris Lifesciences Limited

Milind Digitally signed by Milind Talegaonkar DN: cn=Milind Talegaonkar, o=Eris Lifesciences Limited, ou, Talegaonk email=complianceofficer@erisli fesciences.com, c=IN ar Date: 2024.10.23 12:07:42 +05'30'

_______ Milind Talegaonkar Company Secretary and Compliance Officer Membership No.: A26493

Encl.: a/a

P.S.: Reason for delay: a day’s delay arose due to IT outage.

==> picture [592 x 72] intentionally omitted <==

==> picture [114 x 63] intentionally omitted <==

The Senior Management Team of

Eris Lifesciences Limited

Cordially invites you to a

Webcast

To discuss the financial and operational

performance for

Q2 & H1 FY 25

Day/Date: Friday, 25[th ] October, 2024

Time: 4:30 PM, IST

Join through below link

Click on the link to join:

• https://www.c meeting.com/web3/join/MWUJ3WFVE7VNQ2

We look forward to your participation RSVP: Kruti Raval: kruti@erislifesciences.com